APT Medical Inc. (SHA:688617)
China · Delayed Price · Currency is CNY 279.46
-5.07 (-1.78%)
Aug 1, 2025, 2:45 PM CST
Ligand Pharmaceuticals Market Cap
APT Medical has a market cap or net worth of 39.43 billion as of August 1, 2025. Its market cap has increased by 31.94% in one year.
Market Cap
39.43B
Enterprise Value
38.28B
Revenue
2.17B
Ranking
n/a
PE Ratio
55.08
Stock Price
$279.46
Market Cap Chart
Since January 7, 2021, APT Medical's market cap has increased from 17.14B to 39.43B, an increase of 130.08%. That is a compound annual growth rate of 20.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 39.43B | 9.23% |
| Dec 31, 2024 | 36.09B | 39.61% |
| Dec 29, 2023 | 25.85B | 26.35% |
| Dec 30, 2022 | 20.46B | 9.62% |
| Dec 31, 2021 | 18.67B | 8.94% |
| Jan 7, 2021 | 17.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 408.66B |
| Shenzhen Mindray Bio-Medical Electronics | 274.81B |
| WuXi AppTec | 264.82B |
| Sichuan Biokin Pharmaceutical | 122.38B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.10B |
| Aier Eye Hospital Group | 119.54B |
| Shanghai United Imaging Healthcare | 109.32B |
| Yunnan Baiyao Group Co.,Ltd | 100.44B |